ReviewCureus2025
Infective Endocarditis in Patients With a History of Intravenous Drug Abuse.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phenotype-Based Stratification and Early Prediction of Staphylococcal Infective Endocarditis: Development of a Pragmatic Bedside Score.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infective endocarditis (IE) in people who inject drugs (PWID) has emerged as a growing public health concern. It entails two main issues future medicine will have to face: an increase in patients with substance abuse and the evolution of new microbial threats. The analysis of characteristics of the disease in this group of patients enables us to draw differentiating points. IE in PWID predominantly involves the right side of the heart, mainly the tricuspid valve. The prevalence of the disease is high in developed countries, in regions with a strong impact of drug abuse, particularly in the younger part of populations facing socioeconomic difficulties linked to changing life conditions in postindustrial economic systems. Staphylococcus aureus is by far the most frequent pathogen responsible for the infection in these patients, proportionally outnumbering the prevalence of this species in non-drug users. Also, higher rates of Gram-negative and fungal infections are posing a serious challenge in the treatment process. The Duke Criteria remain the common diagnostic methodology in all cases of IE, with echocardiography - both transthoracic echocardiography (TTE) and transoesophageal echocardiography (TEE) - being staples for imaging. The identification of the pathogen includes both standard microbiologic blood culture tests and the use of advanced biomolecular methods. Management in an optimal therapeutic process requires targeted antimicrobial therapy, which in many cases has to be supported by invasive surgical or percutaneous interventions. The widening spectrum of surgical procedures, such as percutaneous vegetation debulking, transcatheter valve-in-valve implantation, or minimally invasive cardiac surgery, represents a positive change for patients in poor clinical condition who are not suitable for standard cardiothoracic procedures.. While short-term survival seems promising at first, the long-term results are still dissatisfying. The main area for improvement is the need for a multidisciplinary approach that integrates infection management and prevention with addiction treatment. An innovative approach combining these factors could lead to a better prognosis in PWID with IE in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.